Stocks Health care ALC
NYSE · Health careAlcon Inc (ALC)
Alcon Inc reported revenue of $10.4B in fiscal 2025, up 4.9% from a year earlier. Net income was $980M, a net margin of 9.4%. Operating cash flow minus capital spending left $1.7B of free cash flow in fiscal 2025. At December 31, 2025 it held $1.5B in cash against $4.7B of debt. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on February 24, 2026.
Key facts about Alcon Inc
- Net worth
- Alcon Inc has a market value (market cap) of $37B at the latest share price, and shareholders' equity of $22B on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $10.4B (+4.9% year on year), with net income of $980M.
- Cash flow
- In fiscal 2025 operations brought in $2.3B of cash; after $543M of capital spending, free cash flow was $1.7B.
- Latest report
- The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on February 24, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR
What Alcon Inc does
Alcon Inc is registered with the SEC under industry code SIC 3851 (Ophthalmic Goods). Its shares trade on NYSE under the ticker ALC.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $10.4B | $980M | $1.98 | $1.7B |
| 2024 | $9.9B | $1B | $2.05 | $1.6B |
| 2023 | $9.5B | $974M | $1.96 | $730M |
| 2022 | $8.7B | $335M | $0.68 | $581M |
| 2021 | $8.3B | $376M | $0.76 | $645M |
| 2020 | $6.8B | -$531M | -$1.09 | $344M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where ALC ranks in Health care
Dividends
It paid out $166M in cash dividends, 17% of its net income.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2025 | n/a | $166M | 17% |
| 2024 | n/a | $130M | 13% |
| 2023 | n/a | $116M | 12% |
| 2022 | n/a | $100M | 30% |
| 2021 | n/a | $54M | 14% |
| 2020 | n/a | $0 | n/a |
Latest SEC filings
What Alcon Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 10, 2026
- May 15, 2026
- May 5, 2026
- April 2, 2026
- February 24, 2026
- February 24, 2026Annual report (foreign issuer) 20-F · period to December 31, 2025Revenue rose 4.9% to $10.4B versus the prior year; diluted EPS $1.98 versus $2.05.
- February 24, 2026
- January 7, 2026
- December 9, 2025Form DFAN14A filing DFAN14A
- November 12, 2025
Insider trades
What the people running Alcon Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
Questions about ALC
What does Alcon Inc do?
Alcon Inc is a company in the Health care sector, listed on NYSE as ALC. Its shares trade on NYSE under the ticker ALC.
What is Alcon Inc's net worth?
Alcon Inc has a market value (market cap) of $37B at the latest share price, and shareholders' equity of $22B on its balance sheet at December 31, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Alcon Inc profitable?
Yes. In fiscal 2025 it reported net income of $980M on revenue of $10.4B, a net margin of 9.4%.
How much revenue does Alcon Inc make?
In fiscal 2025 Alcon Inc reported revenue of $10.4B. That is 4.9% more than a year earlier.
When did Alcon Inc last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on February 24, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from August 10, 2026.
Similar companies
Compare ALC with
Follow ALC
Get an email when Alcon Inc files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Alcon Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.